This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sekisui Medical Co., Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Remi Ikeda: Innovator in Thrombin Stabilization
Introduction
Remi Ikeda is a notable inventor based in Ryugasaki, Japan. He has made significant contributions to the field of medical technology, particularly in the stabilization of thrombin, a crucial protein in blood coagulation.
Latest Patents
Ikeda holds a patent for a method aimed at stabilizing unstable α-thrombin in thrombin-containing solutions. This innovative method involves adjusting the percentage of α-thrombin to 70% or more relative to the total thrombin in the solution. The patent is titled "Method for stabilizing α-thrombin in thrombin-containing solution," and it provides a solution containing stabilized α-thrombin, as well as a liquid fibrinogen assay reagent that incorporates this stabilized solution.
Career Highlights
Remi Ikeda is associated with Sekisui Medical Co., Ltd., where he applies his expertise in medical innovations. His work focuses on enhancing the reliability and effectiveness of thrombin-related medical applications.
Collaborations
Ikeda collaborates with talented professionals in his field, including Chizuru Morikawa and Hirokazu Yago. These collaborations contribute to the advancement of medical technologies and the development of innovative solutions.
Conclusion
Remi Ikeda's work in stabilizing α-thrombin represents a significant advancement in medical technology. His contributions are vital for improving thrombin-related applications in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile